Document is current
Any future updates will be listed below
-
Authors
Ohara, Masatsugu
Kozuka, Ritsuzo
Uchida, Yoshihito
Iino, Chikara
Sasaki, Ryo
Tojima, Hiroki
Kawata, Kazuhito
Kakizaki, Satoru
Tokumoto, Yoshio
Endo, Mizuki
Asai, Akira
Inoue, Jun
Nagata, Kenji
Takahashi, Hirokazu
Shimakami, Tetsuro
Ogawa, Koji
Enomoto, Masaru
Ikegami, Tadashi
Ide, Tatsuya
Sakamoto, Naoya
Korenaga, Masaaki https://orcid.org/0000-0002-6360-8297
-
Funding
Funding for this research was provided by:
Ministry of Health, Labour and Welfare (23HC1001)
Japan Institute for Health Security
- License Information
-
More Information
Article History
Received: 9 November 2025
Accepted: 8 January 2026
First Online: 27 January 2026
Declarations
:
: Prof. Tadashi Ikegami received lecture fees from AbbVie GK and Gilead Sciences, Inc. Dr. Jun Inoue received honoraria from Gilead Sciences, Inc. Prof. Hirokazu Takahashi received research grants from Sysmex, Takeda, Kracie, and Miz, and honoraria for lectures from Novo Nordisk, AbbVie, and Lilly. Dr. Satoshi Kakizaki received lecture fees from AbbVie Inc. Prof. Naoya Sakamoto received lecture fees from Chugai Pharmaceutical Co., Ltd. and research grants from Gilead Sciences, Inc. and AbbVie, Inc. The other authors declare no conflicts of interest related to this study.
